Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Anne Marie Lane, M.P.H.

Co-Author

This page shows the publications co-authored by Anne Marie Lane and Evangelos Gragoudas.
Connection Strength

5.445
  1. Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma. JAMA Ophthalmol. 2018 09 01; 136(9):981-986.
    View in: PubMed
    Score: 0.805
  2. Long-term Risk of Melanoma-Related Mortality After Uveal Melanoma--Reply. JAMA Ophthalmol. 2016 Feb; 134(2):239-40.
    View in: PubMed
    Score: 0.673
  3. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy. JAMA Ophthalmol. 2015 Jul; 133(7):792-6.
    View in: PubMed
    Score: 0.646
  4. Proton irradiation for peripapillary and parapapillary melanomas. Arch Ophthalmol. 2011 Sep; 129(9):1127-30.
    View in: PubMed
    Score: 0.496
  5. Mortality after diagnosis of small melanocytic lesions of the choroid. Arch Ophthalmol. 2010 Aug; 128(8):996-1000.
    View in: PubMed
    Score: 0.460
  6. Adjuvant interferon therapy for patients with uveal melanoma at high risk of metastasis. Ophthalmology. 2009 Nov; 116(11):2206-12.
    View in: PubMed
    Score: 0.432
  7. Conservative management of suspicious melanocytic lesions of the iris. Graefes Arch Clin Exp Ophthalmol. 2019 Jun; 257(6):1319-1324.
    View in: PubMed
    Score: 0.209
  8. An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma. Melanoma Res. 1997 Jun; 7(3):237-42.
    View in: PubMed
    Score: 0.185
  9. Ranibizumab for the Prevention of Radiation Complications in Patients Treated With Proton Beam Irradiation for Choroidal Melanoma. Trans Am Ophthalmol Soc. 2016 Aug; 114:T2.
    View in: PubMed
    Score: 0.174
  10. Posterior uveal melanoma in young patients treated with proton beam therapy. Retina. 2010 Sep; 30(8):1267-71.
    View in: PubMed
    Score: 0.116
  11. Survival in patients with presymptomatic diagnosis of metastatic uveal melanoma. Arch Ophthalmol. 2010 Jul; 128(7):871-5.
    View in: PubMed
    Score: 0.114
  12. Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma. Ophthalmology. 2010 Aug; 117(8):1617-22.
    View in: PubMed
    Score: 0.112
  13. Proton beam irradiation for neovascular age-related macular degeneration. Ophthalmology. 2006 Nov; 113(11):2012-9.
    View in: PubMed
    Score: 0.088
  14. Treatment of metastatic tumors of the choroid with proton beam irradiation. Ophthalmology. 2005 Feb; 112(2):337-43.
    View in: PubMed
    Score: 0.079
  15. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol. 2002 Dec; 120(12):1665-71.
    View in: PubMed
    Score: 0.068
  16. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol Soc. 2002; 100:43-8; discussion 48-9.
    View in: PubMed
    Score: 0.063
  17. A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma. Arch Ophthalmol. 2000 Jun; 118(6):773-8.
    View in: PubMed
    Score: 0.057
  18. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol. 1999 Sep; 117(9):1161-73.
    View in: PubMed
    Score: 0.054
  19. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology. 1999 Aug; 106(8):1571-7; discussion 1577-8.
    View in: PubMed
    Score: 0.054
  20. Evaluation of choroidal lesions with swept-source optical coherence tomography. Br J Ophthalmol. 2019 01; 103(1):88-93.
    View in: PubMed
    Score: 0.049
  21. Genetic Risk Factors for Radiation Vasculopathy. Invest Ophthalmol Vis Sci. 2018 03 01; 59(3):1547-1553.
    View in: PubMed
    Score: 0.049
  22. Long-term Outcomes After Proton Beam Irradiation in Patients With Large Choroidal Melanomas. JAMA Ophthalmol. 2017 11 01; 135(11):1191-1196.
    View in: PubMed
    Score: 0.047
  23. Systematic genomic and translational efficiency studies of uveal melanoma. PLoS One. 2017; 12(6):e0178189.
    View in: PubMed
    Score: 0.046
  24. Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea. Ophthalmology. 2016 Feb; 123(2):369-377.
    View in: PubMed
    Score: 0.041
  25. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations. JAMA Ophthalmol. 2015 Aug; 133(8):881-7.
    View in: PubMed
    Score: 0.041
  26. Ocular blood flow velocity in age-related macular degeneration. Ophthalmology. 1995 Apr; 102(4):640-6.
    View in: PubMed
    Score: 0.040
  27. Outcomes of proton therapy for the treatment of uveal metastases. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1044-50.
    View in: PubMed
    Score: 0.038
  28. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One. 2012; 7(4):e35295.
    View in: PubMed
    Score: 0.032
  29. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation. Int J Radiat Oncol Biol Phys. 2011 Mar 01; 79(3):842-6.
    View in: PubMed
    Score: 0.028
  30. Proton beam irradiation using a light-field technique for the treatment of choroidal hemangiomas. Ophthalmologica. 2010; 224(4):209-16.
    View in: PubMed
    Score: 0.027
  31. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization. Invest Ophthalmol Vis Sci. 2006 Jun; 47(6):2623-31.
    View in: PubMed
    Score: 0.022
  32. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma. Int J Radiat Oncol Biol Phys. 2006 Mar 15; 64(4):1018-22.
    View in: PubMed
    Score: 0.021
  33. Effect of intravitreal injection of ranibizumab in combination with verteporfin PDT on normal primate retina and choroid. Invest Ophthalmol Vis Sci. 2006 Jan; 47(1):357-63.
    View in: PubMed
    Score: 0.021
  34. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. Arch Ophthalmol. 2005 Apr; 123(4):509-16.
    View in: PubMed
    Score: 0.020
  35. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol. 2000 Mar; 118(3):327-36.
    View in: PubMed
    Score: 0.014
  36. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol. 1999 Sep; 117(9):1177-87.
    View in: PubMed
    Score: 0.013
  37. Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol. 1998 May; 236(5):365-74.
    View in: PubMed
    Score: 0.012
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.